Product Information
DESCOVY 120-15 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $71.3575 per EA under NDC 61958200501. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
120; 15 mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958200501
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA208215On Market Since
1/7/2022
Pharmacological Classes
Price Statistics
The NADAC for DESCOVY 120-15 MG TABLET has been published 80 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $71.3575 per EA |
|---|---|
| All-time high | $71.4142 (Jan 14, 2026) |
| All-time low | $71.0547 (Dec 18, 2024) |
| 52-week high | $71.4142 |
| 52-week low | $71.2171 |
| Median price | $71.2701 |
| Average price | $71.2487 |
| Largest weekly change | +0.2% (May 21, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the emtricitabine and tenofovir alafenamide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DESCOVY 120-15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESCOVY 120-15 MG TABLET, manufactured by Gilead Sciences, Inc., is $71.3575 per EA (NDC 61958200501), effective Jun 24, 2026.
How has the price of DESCOVY 120-15 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESCOVY 120-15 MG TABLET has held within roughly two percent of its current level. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for DESCOVY 120-15 MG TABLET?
Since Dec 18, 2024, the NADAC for DESCOVY 120-15 MG TABLET has ranged from a low of $71.0547 (Dec 18, 2024) to a high of $71.4142 (Jan 14, 2026), with a median of $71.2701 per EA.
Are there cheaper alternatives to DESCOVY 120-15 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DESCOVY 120-15 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures DESCOVY 120-15 MG TABLET?
DESCOVY 120-15 MG TABLET (NDC 61958200501) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification